Novo Nordisk's Bloomington facility received an OAI label from the FDA due to compliance issues, including contamination by extrinsic particles. Scholar Rock's drug application was rejected due to ...
It appears problems at Novo Nordisk’s recently acquired manufacturing facility in Indiana aren’t going to be solved any time ...
The FDA has declared a Novo Nordisk plant, key to drug manufacturing for some biotechs, out of compliance, which could delay ...
Novo Nordisk A/S is forcing some workers to accept demotions in order to keep their jobs as the drugmaker continues to lay ...
Novo Nordisk, the 102-year-old Danish drugmaker behind the blockbuster drugs Ozempic and Wegovy, is laying off thousands of workers as it seeks to recoup some of the revenue it’s lost to competitors ...
Wegovy-maker Novo Nordisk will cut 9,000 jobs, or about 11.5% of its workforce, in a restructuring to save $1.26 billion annually, it said on Wednesday, as it battles rising pressure from US rival Eli ...
Armed with hundreds of thousands of dollars from Newman’s Own Foundation and Ozempic creator Novo Nordisk, young Native ...